- Motley Fool•23 hours ago
It only took four drugs to do it.
- Investor's Business Daily•2 days ago
Late Thursday, BioMarin reported 2016 losses that grew for at least a third year — prompting the stock to plunge Friday.
- Zacks•2 days ago
BioMarin Pharmaceutical Inc. (BMRN) reported a loss of 37 cents per share in the fourth quarter of 2016.
BMRN : Summary for BioMarin Pharmaceutical Inc. - Yahoo Finance
BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||85.01 x 1000|
|Ask||87.50 x 100|
|Day's Range||85.88 - 88.82|
|52 Week Range||73.45 - 102.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-29.52|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|